Sakuma Y, Mita H
Arerugi. 1989 Feb;38(2):93-7.
The inhibitory effect of 0.25% AA-673 eye drops on histamine release in tears was examined by an ocular provocation test with antigen in 11 patients with Japanese cedar pollinosis during the off-season. AA-673 eye drops were administered into the right eye, while the left eye was given placebo eye drops. Five minutes later, a cedar antigen solution at 1:20 w/v was applied to the eyes. Levels of histamine in collected tears were determined by radioimmunoassay. Histamine levels in tears before, and 5 min and 10 min after provocation amounted to 0.2 +/- 0.2 ng/ml, 1.2 +/- 1.3 ng/ml and 1.3 +/- 1.6 ng/ml, respectively, while they were 0.2 +/- 0.2 ng/ml, 3.4 +/- 2.4 ng/ml and 3.6 +/- 3.6 ng/ml in the placebo-treated eyes at the same time points, showing a significant inhibitory effect of the drug on histamine release in the eyes treated with AA-673 (p less than 0.01 at 5 min; p less than 0.05 at 10 min). Inhibition rates of AA-673 eye drops on histamine release were 73.0% at 5 min and 69.6% at 10 min after provocation, indicating the excellent effect of this preparation in inhibiting histamine release. From the above findings it is considered that 0.25% AA-673 eye drops are an effective new therapeutic agent for Japanese cedar pollinosis.
在花粉淡季,对11名日本雪松花粉症患者进行了抗原眼激发试验,以检测0.25% AA - 673滴眼液对泪液中组胺释放的抑制作用。将AA - 673滴眼液滴入右眼,左眼滴入安慰剂滴眼液。5分钟后,将1:20 w/v的雪松抗原溶液滴入眼中。通过放射免疫分析法测定收集的泪液中的组胺水平。激发前、激发后5分钟和10分钟时,泪液中组胺水平分别为0.2±0.2 ng/ml、1.2±1.3 ng/ml和1.3±1.6 ng/ml,而在同一时间点,安慰剂治疗眼的组胺水平分别为0.2±0.2 ng/ml、3.4±2.4 ng/ml和3.6±3.6 ng/ml,表明该药物对AA - 673治疗眼的组胺释放具有显著抑制作用(5分钟时p<0.01;10分钟时p<0.05)。激发后5分钟和10分钟时,AA - 673滴眼液对组胺释放的抑制率分别为73.0%和69.6%,表明该制剂在抑制组胺释放方面效果良好。从上述结果认为,0.25% AA - 673滴眼液是治疗日本雪松花粉症的一种有效的新型治疗药物。